Aptevo Therapeutics Inc.
APVO
Revenue
3.11M
▼-551.00k▼-15.03%
3 Months ChangeAssets
27.00M
▲11.37M▲72.79%
3 Months ChangeLiabilities
9.60M
▲504.00k▲5.54%
3 Months ChangeFree Cash Flow
-7.70M
▲6.30M▲45.02%
24 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-19
Form 8-K
ID: 0001193125-26-057707
2026-02-03
Form 8-K
ID: 0001193125-26-034473
2026-01-09
Form 8-K
ID: 0001193125-26-008318
2025-12-29
Form 8-K
ID: 0001193125-25-335497
2025-12-09
Form 8-K
ID: 0001193125-25-312972
2025-11-06
Form 10-Q
ID: 0001193125-25-269598
2025-11-06
Form 8-K
ID: 0001193125-25-269470
2025-10-30
Form 8-K
ID: 0001193125-25-258665
2025-09-16
Form 8-K
ID: 0001193125-25-205107
2025-09-04
Form 8-K
ID: 0001671584-25-000005